Texas Roadhouse, Inc. (NASDAQ:TXRH) will release earnings for its fourth quarter after the closing bell on Thursday, Feb. 19.Analysts expect the company to report quarterly earnings of $1.5 per share. That’s down from $1.73 per share in the year-ago period. The consensus estimate for Texas Roadhouse's quarterly revenue is $1.5 billion (it reported $1.44 billion last year), according to Benzinga Pro.Ahead of quarterly earnings, Mizuho analyst Nick Setyan, on Feb. 12, maintained Texas Roadhouse with an Outper ...

Core Insights - Coca-Cola Co. has experienced a significant drop in its Benzinga Edge value score from 17.86 to 3.28, indicating a potential overvaluation after a 15% year-to-date stock gain following its Q4 2025 earnings report [1][2]. Financial Performance - The company's fourth-quarter earnings report showed mixed results, with adjusted earnings per share of $0.58 beating expectations, but revenue of $11.80 billion fell short of the $12.02 billion forecast, marking the first revenue miss in five years [3]. - The stock's recent double-digit gains, combined with the revenue shortfall, have led to its placement in the bottom 10% of stocks for relative worth [3]. Valuation Concerns - The current value score of 3.28 suggests a significant disconnect between the stock's market price and its underlying operating performance, raising concerns about its valuation [4]. - As leadership transitions to Henrique Braun on March 31, the company faces the challenge of demonstrating its ability to regain market confidence without further valuation corrections [4]. Market Performance - Year-to-date, Coca-Cola's shares have increased by 15%, outperforming the S&P 500 index, which rose only 0.33% during the same period [5]. - Over the last six months, the stock has risen by 13.35%, and by 13.44% over the past year, although it was down 0.24% in premarket trading on Thursday [5].

Economist Mohamed El-Erian took to X (formerly Twitter) on Thursday morning with a question after Blue Owl Capital Inc (NYSE:OWL) permanently halted redemption at its retail private credit fund.“Is this a ‘canary-in-the-coalmine’ moment, similar to August 2007?” El-Erian wrote, citing a Financial Times report that Blue Owl “will permanently restrict investors from withdrawing their cash from its inaugural private retail debt fund.” The idiom references the historical mining practice of using caged canaries ...

Meta Platforms (NASDAQ:META) is reviving its previously shelved “Malibu 2” project, with plans to launch its debut smartwatch in 2026. The watch is anticipated to offer health tracking features and an integrated Meta AI assistant, The Information reported on Wednesday. The revival of this project marks a significant return for AI-powered wearables, particularly in the health and fitness industry. The report also indicated that Meta has roughly four augmented reality (AR) and mixed reality (MR) glasses under ...

Akamai Technologies, Inc. (NASDAQ:AKAM) will release earnings results for its fourth quarter, after the closing bell on Thursday, Feb. 19.Analysts expect the Cambridge, Massachusetts-based company to report quarterly earnings at $1.75 per share, up from $1.66 per share in the year-ago period. The consensus estimate for Akamai's quarterly revenue is $1.08 billion, versus $1.02 billion a year earlier, according to data from Benzinga Pro.On Dec. 17, Akamai partnered with Visa Inc. (NYSE:V) to enhance identity ...

Earnings Report - Akamai Technologies, Inc. is set to release its fourth-quarter earnings results on February 19, with analysts expecting earnings of $1.75 per share, an increase from $1.66 per share in the same period last year [1] - The consensus estimate for quarterly revenue is $1.08 billion, compared to $1.02 billion a year earlier [1] Partnership and Stock Performance - On December 17, Akamai partnered with Visa Inc. to enhance identity verification, user recognition, and security for agentic commerce [2] - Following this partnership, Akamai's shares increased by 0.8%, closing at $109.31 [2]

President Donald Trump claimed on Wednesday that his administration's aggressive tariff policies have sparked a "staggering" 78% reduction in the U.S. trade deficit, vowing the nation will soon achieve its first trade surplus in decades.A Milestone In Trade Policy?In an all-caps post on Truth Social, the President lauded the impact of his global “reciprocal tariffs,” which targeted over 100 countries starting in April 2025.Trump attributed the contraction directly to these duties, stating, "The United State ...

Carvana Co. (NYSE:CVNA) shares slipped in premarket trading on Thursday as investors weighed fresh earnings details and cost pressures.The online used-vehicle retailer delivered stronger revenue than expected, yet mounting operational expenses and short-seller scrutiny shaped early sentiment around the stock.Quarterly PerformanceCarvana posted fourth-quarter revenue of nearly $5.6 billion, surpassing analyst projections that tracked closer to $5.26 billion. The company also disclosed earnings of $4.22 per s ...

Two long and one inverse fund continue Tradr's tradition of launching first-to-market strategiesNEW YORK, Feb. 19, 2026 /PRNewswire/ -- Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, today launched three new leveraged ETFs on single stocks. The Cboe-listed funds seek to deliver either two times the inverse (-200%) or two times long (200%) the daily performance of a specific underlying stock. All three ETFs are first-to-market strategies.The following ETFs are e ...

Zinger Key Point:MTX240's mechanistic novelty may give it a long-awaited edge in treatments for gastrointestinal stromal tumors (GIST)Biodexa Pharmaceuticals PLC (NASDAQ:BDRX) , a clinical-stage biopharmaceutical company developing a pipeline of innovative products for the treatment of rare diseases with an increasing focus on products to treat or prevent gastrointestinal cancers, has added a new phase 1-ready candidate to its portfolio, this time to target gastrointestinal stromal tumors, or GIST. MTX240's ...